Stephen Willey
Stock Analyst at Stifel
(3.14)
# 1,160
Out of 4,712 analysts
120
Total ratings
40.66%
Success rate
2.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals | Maintains: Buy | $5 → $4 | $0.58 | +589.66% | 2 | Nov 14, 2024 | |
| IGMS IGM Biosciences | Maintains: Buy | $25 → $27 | $6.40 | +321.88% | 6 | Nov 11, 2024 | |
| ABCL AbCellera Biologics | Reiterates: Buy | $14 → $12 | $2.95 | +306.78% | 4 | Nov 5, 2024 | |
| ZYME Zymeworks | Maintains: Buy | $21 → $28 | $14.14 | +98.02% | 6 | Oct 28, 2024 | |
| EXEL Exelixis | Maintains: Hold | $26 → $30 | $33.82 | -11.30% | 16 | Oct 16, 2024 | |
| BCAX Bicara Therapeutics | Initiates: Buy | $47 | $19.12 | +145.82% | 1 | Oct 8, 2024 | |
| CUE Cue Biopharma | Maintains: Buy | $8 → $4 | $1.01 | +296.04% | 7 | Aug 20, 2024 | |
| INSM Insmed | Maintains: Buy | $74 → $88 | $70.53 | +24.77% | 4 | Aug 9, 2024 | |
| HLVX HilleVax | Downgrades: Hold | $34 → $3 | $1.87 | +60.43% | 3 | Jul 9, 2024 | |
| GERN Geron | Maintains: Buy | $6 → $7 | $3.34 | +109.58% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $19.57 | +37.97% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $6 → $1.5 | $0.51 | +192.51% | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $29 → $7 | $3.26 | +114.72% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $2.36 | +196.61% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $0.87 | +1,272.21% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $68 | $69.91 | -2.73% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.60 | +150.00% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $38.42 | +61.37% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $2.35 | +665.96% | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.50 | +500.00% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.53 | +239.94% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.83 | +15,637.70% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $0.11 | +265,758.21% | 1 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $0.94 | +2,140.00% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $0.76 | +427.84% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $243.25 | -49.43% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $36.53 | +28.66% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $66.63 | +63.59% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $17.78 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $0.24 | +10,230.58% | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $5.90 | +289.83% | 5 | Feb 7, 2018 |
X4 Pharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $0.58
Upside: +589.66%
IGM Biosciences
Nov 11, 2024
Maintains: Buy
Price Target: $25 → $27
Current: $6.40
Upside: +321.88%
AbCellera Biologics
Nov 5, 2024
Reiterates: Buy
Price Target: $14 → $12
Current: $2.95
Upside: +306.78%
Zymeworks
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $14.14
Upside: +98.02%
Exelixis
Oct 16, 2024
Maintains: Hold
Price Target: $26 → $30
Current: $33.82
Upside: -11.30%
Bicara Therapeutics
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $19.12
Upside: +145.82%
Cue Biopharma
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $1.01
Upside: +296.04%
Insmed
Aug 9, 2024
Maintains: Buy
Price Target: $74 → $88
Current: $70.53
Upside: +24.77%
HilleVax
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.87
Upside: +60.43%
Geron
Jun 10, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $3.34
Upside: +109.58%
May 15, 2024
Maintains: Buy
Price Target: $27
Current: $19.57
Upside: +37.97%
May 15, 2024
Downgrades: Hold
Price Target: $6 → $1.5
Current: $0.51
Upside: +192.51%
May 10, 2024
Downgrades: Hold
Price Target: $29 → $7
Current: $3.26
Upside: +114.72%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.36
Upside: +196.61%
Mar 21, 2024
Maintains: Buy
Price Target: $15 → $12
Current: $0.87
Upside: +1,272.21%
Mar 12, 2024
Reiterates: Hold
Price Target: $68
Current: $69.91
Upside: -2.73%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.60
Upside: +150.00%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $38.42
Upside: +61.37%
May 12, 2023
Maintains: Buy
Price Target: $21 → $18
Current: $2.35
Upside: +665.96%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $1.50
Upside: +500.00%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $3.53
Upside: +239.94%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.83
Upside: +15,637.70%
Mar 25, 2020
Initiates: Buy
Price Target: $285
Current: $0.11
Upside: +265,758.21%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $0.94
Upside: +2,140.00%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $0.76
Upside: +427.84%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $243.25
Upside: -49.43%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $36.53
Upside: +28.66%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $66.63
Upside: +63.59%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $17.78
Upside: -
Mar 7, 2018
Maintains: Buy
Price Target: $23 → $25
Current: $0.24
Upside: +10,230.58%
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $5.90
Upside: +289.83%